Nicotinamide riboside comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-04. Numbers and descriptions here follow the published literature rather than marketing material.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. The compound exists in cells as an intermediate in the production of nicotinamide adenine dinucleotide, a central redox cofactor. NMN is distinct from nicotinamide riboside, another related pyridine nucleotide, although the two compounds can converge in metabolic pathways. Its chemical formula is C11H15N2O8P, and it carries a net negative charge at physiological pH.
In the salvage pathway, NMN is generated from nicotinamide and 5-phosphoribosyl-1-pyrophosphate by the enzyme nicotinamide phosphoribosyltransferase. A second route produces NMN from nicotinamide riboside through phosphorylation by nicotinamide riboside kinases. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferases, often called NMNAT enzymes. This stepwise route allows cells to recycle nicotinamide and maintain NAD+ levels under changing metabolic conditions. The relative contribution of each route varies by tissue, species, and physiological state, and it remains an active area of research.
Research on NMN has expanded because NAD+ concentrations decline with age in some tissues and because NAD+ participates in energy metabolism, DNA repair, and signaling. Animal studies have reported changes in NAD+ levels after NMN administration, but human data are more limited and often focus on safety, pharmacokinetics, and biomarker changes. Questions remain about oral absorption, tissue distribution, and whether changes in blood NAD+ reflect changes inside specific organs. NMN is not an approved drug, and claims about its clinical effects should be distinguished from established biochemical findings.
Inside cells, the enzyme nicotinamide phosphoribosyltransferase, or NAMPT, converts nicotinamide and a ribose-phosphate donor into NMN. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+. NAD+ participates in redox reactions and serves as a substrate for signaling enzymes such as sirtuins, PARPs, and CD38. Because NAD+ levels tend to decline with age in many organisms, NMN has drawn interest as a possible way to influence that decline. Whether oral NMN reliably raises NAD+ in human tissues, and whether any such change modifies disease risk, remain open research questions.
NMN is present in small amounts in some foods, including certain vegetables, fruits, and animal products, but food content varies widely and is not well standardized. In laboratory research, NMN is used as a tool compound to study NAD+ metabolism, mitochondrial function, and cellular stress responses. Animal studies have reported changes in NAD+ levels and various physiological measures after NMN administration, but species differences and study designs limit direct extrapolation to humans. Human trials have largely focused on safety, tolerability, and pharmacokinetics, with fewer studies examining clinical endpoints.
| Property | Value | Notes |
|---|---|---|
| Chemical formula | C11H15N2O8P | Pyridinium nucleotide; free acid form |
| Molar mass | 334.22 g/mol | Free acid; salt forms differ |
| Appearance | White to off-white powder | Typical reference material |
| Solubility class | Water-soluble | Hygroscopic under humid conditions |
| Common synonyms | Nicotinamide mononucleotide; NMN | Distinct from nicotinamide riboside |
Small amounts of NMN occur in some foods, including certain vegetables, fruits, and animal products, though the quantities are generally low and variable. Human cells also synthesize NMN internally from nicotinamide and other precursors. Research interest increased after studies examined whether raising NAD+ levels affects metabolism and aging-related pathways in animals. Evidence in humans remains limited and mixed for many outcomes, and questions about effective absorption, tissue delivery, and long-term effects are still open. Regulatory status differs by country, with some markets treating NMN as a supplement ingredient and others restricting its sale.
Nicotinamide mononucleotide, usually shortened to NMN, is a naturally occurring nucleotide. Its structure consists of a nicotinamide base linked to a ribose sugar that carries a phosphate group. In cells, NMN serves as an intermediate in the salvage pathway that produces nicotinamide adenine dinucleotide, or NAD+. Because NAD+ participates in many oxidation-reduction reactions, NMN sits near central metabolic processes. The compound is not a drug in most jurisdictions and is discussed mainly in biochemistry and nutrition research.
The term NMN commonly refers to the beta isomer, in which the nicotinamide group is attached to the ribose through a beta-glycosidic bond. Commercial material may be supplied as the free acid or as a salt, such as a sodium salt, which affects molecular weight and water solubility. Related compounds include nicotinamide riboside and NAD+ itself, but these are distinct molecules with different formulas and cellular handling. Laboratory research often uses the beta form because it matches the naturally occurring configuration found in biological systems.
Dietary sources of NMN include small amounts in certain vegetables, fruits, and other foods, although exact values vary by sample and method. Endogenous NMN concentrations are tightly regulated and often low, making measurement in blood or tissues technically demanding. After oral intake, NMN is thought to be rapidly metabolized in the intestine and liver, and intact NMN may not reach all tissues at high levels. Some rodent studies report increases in tissue NAD+ after oral NMN, while human data remain limited and sometimes rely on blood NAD+ metabolites rather than direct tissue measures.
Research on NMN has focused on aging, metabolic regulation, exercise capacity, and insulin sensitivity, but findings are preliminary. Many human trials are small, short in duration, and use different endpoints, which complicates comparison across studies. No national regulator has approved NMN as a therapeutic drug for any indication. In some countries it is sold as a supplement or research chemical, while other jurisdictions have questioned its status under food or supplement laws. Claims about extending human lifespan or reversing aging are not supported by established clinical evidence.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide base with a ribose sugar and a phosphate group. Within cells, NMN sits on the biosynthetic route that recycles nicotinamide back into nicotinamide adenine dinucleotide, or NAD+. Because NAD+ participates in redox reactions and signaling, enzymes that produce and consume it influence many metabolic processes. The compound is therefore best described as an intermediate rather than a final signaling molecule.
In the canonical salvage pathway, nicotinamide phosphoribosyltransferase, known as NAMPT, transfers a phosphoribosyl group to nicotinamide and releases NMN. A second enzyme, NMN adenylyltransferase, then attaches an adenylyl group to NMN to form NAD+. Alternative routes exist, including a pathway that uses nicotinamide riboside and its phosphorylated forms. The relative contribution of extracellular NMN to intracellular NAD+ pools remains an area of active investigation, and the roles of specific transporters and enzymes are not completely defined.
For outside planting, USDA Zone 9 or higher is recommended. In nature, Mimosa tenuiflora "[...] fruits and seeds are disseminated by the wind in a radius of 5–8 m (16–26 ft) from the mother plant; rain carries them from slopes to lower plains and human activities contribute to their dissemination." For cultivation, the seed pods are collected once they start to spontaneously open on the tree. The collected pods are laid out in the sun so that the pods open up and release their seeds. The seeds can then be planted in sandy soil with sun exposure. Scarification of the seed via mechanical means or by using sulfuric acid greatly increases the germination rate of the seeds over non-treatment. The seeds can be sown directly into holes in the ground or planted in prepared areas. The seeds can germinate in temperatures ranging from 10 to 30 °C, but the highest germination rate occurs at around 25 °C (about 96%), even after four years of storage. Germination takes about 2–4 weeks. It is also possible to propagate Mimosa tenuiflora via cuttings. Trimming adult Mimosa tenuiflora during the rainy season is not recommended as it can kill them.
=== Laminin EGF-like === Beside different types of globular domains each laminin subunit contains, in its first half, consecutive repeats of about 60 amino acids in length that include eight conserved cysteines. The tertiary structure of this domain is remotely similar in its N-terminus to that of the EGF-like module. It is also known as a 'LE' or 'laminin-type EGF-like' domain. The number of copies of the laminin EGF-like domain in the different forms of laminins is highly variable; from 3 up to 22 copies have been found. In mouse laminin gamma-1 chain, the seventh LE domain has been shown to be the only one that binds with a high affinity to nidogen. The binding-sites are located on the surface within the loops C1-C3 and C5-C6. Long consecutive arrays of laminin EGF-like domains in laminins form rod-like elements of limited flexibility, which determine the spacing in the formation of laminin networks of basement membranes.
hydrogen bond A form of electrostatic interaction between an electronegative atom and a hydrogen atom bound to a second electronegative atom. Hydrogen bonding is unique because the small size of the hydrogen atoms permits proximity of the interacting electrical charges, and may occur as an intermolecular or intramolecular force.
18 August – Researchers in Austria propose coupling an electron microscope to a trapped-ion quantum computer, allowing quantum information from successive electrons to be combined and potentially enabling high-resolution imaging with fewer electrons, reducing damage to sensitive samples. 19 August – Astronomers report the discovery of S301, the closest and fastest star yet observed orbiting Sagittarius A*, the supermassive black hole at the centre of the Milky Way. The star completes an orbit every 8.7 years and reaches about 25,000 km/s, or 8.5% of the speed of light, at its closest approach. Its unusually tight orbit may enable a direct measurement of Sagittarius A*'s spin within about a decade. 23 August – A review published in Global Challenges finds that no place on Earth is resilient to all of the major global catastrophic risks considered. Australia shows resilience across the widest range of scenarios, while geographic isolation, food self-sufficiency, high-quality governance and decentralisation emerge as recurring resilience factors. 26 August University College London reports that London neurosurgeons have performed the first AI-assisted brain surgery at the National Hospital for Neurology and Neurosurgery in a 48-year-old patient who was diagnosed with a brain tumour in 2024. The U.S. Food and Drug Administration approves the RAS inhibitor drug daraxonrasib as a treatment for metastatic pancreatic cancer. 30 August – NASA launches the flagship Nancy Grace Roman Space Telescope aboard a SpaceX Falcon Heavy rocket from the Kennedy Space Center in Florida.
Sources: en.wikipedia.org
The other common method for introducing the Fmoc group is through 9-fluorenylmethylsuccinimidyl carbonate (Fmoc-OSu), which may itself be obtained by the reaction of Fmoc-Cl with the dicyclohexylammonium salt of N-hydroxysuccinimide. Reacting with 9-fluorenylmethyloxycarbonyl azide (itself made by reacting Fmoc-Cl with sodium azide) in sodium bicarbonate and aqueous dioxane is also a method to install Fmoc group. Because the fluorenyl group is highly fluorescent, certain UV-inactive compounds may be reacted to give the Fmoc derivatives, suitable for analysis by reversed phase HPLC. Analytical uses of Fmoc-Cl that do not use chromatography may be limited by the requirement that excess Fmoc-Cl be removed before an analysis of fluorescence.
Barnum Brown, assistant curator of the American Museum of Natural History, found the first partial skeleton of T. rex in eastern Wyoming in 1900. Brown found another partial skeleton in the Hell Creek Formation in Montana in 1902, comprising approximately 34 fossilized bones. Writing at the time Brown said "Quarry No. 1 contains the femur, pubes, humerus, three vertebrae and two undetermined bones of a large Carnivorous Dinosaur not described by Marsh. ... I have never seen anything like it from the Cretaceous." Henry Fairfield Osborn, president of the American Museum of Natural History, named the second skeleton T. rex in 1905. The generic name is derived from the Greek words τύραννος (tyrannos, meaning "tyrant") and σαῦρος (sauros, meaning "lizard"). Osborn used the Latin word rex, meaning "king", for the specific name. The full binomial therefore translates to "tyrant lizard the king" or "King Tyrant Lizard", emphasizing the animal's size and presumed dominance over other species of the time.
Metal rods can be surgically inserted in the long bones to improve strength, a procedure developed by Harold A. Sofield when he was Chief of Staff at Chicago's Shriners Hospitals for Children, a hospital that offers orthopedic care and surgery to children regardless of their family's ability to pay. Large numbers of children with OI came to Shriners, and Sofield experimented with various methods to strengthen their bones. In 1959, with Edward A. Millar [sic], Sofield wrote a seminal article describing a three-part surgery that seemed radical at the time: precisely breaking the bones ("fragmentation"), putting the resulting bone fragments in a straight line ("realignment"), then placing metal rods into the intramedullary canals of the long bones to stabilize and strengthen them ("rod fixation"). His treatment proved useful for increasing the mobility of people with OI, and it has been adopted throughout the world—it became standard surgical treatment for severe OI by 1979, in which year David Sillence found that ≈2⁄3 of the patients he surveyed with OI type III had undergone at least one rodding surgery. Rodding surgery is often done with the hope that it will offer a path to ambulation, walking, to patients with moderate or severe OI.
Hide glue is made from animal hide (animal skin) and is often used in woodworking. It may be supplied as granules, flakes, or flat sheets, which have an indefinite shelf life if kept dry. It is dissolved in water, heated and applied warm, typically around 60 °C (140 °F). Warmer temperatures quickly destroy the strength of hide glue. Commercial glue pots, simple water baths or double boilers may be used to keep the glue hot while in use. As hide glue cools, it gels quickly. At room temperature, prepared hide glue has the consistency of stiff gelatin, which is in fact a similar composition. Gelled hide glue does not have significant strength, so it is vital to apply the glue, fit the pieces, and hold them steady before the glue temperature drops much below 50 °C (120 °F). All glues have an open time, the amount of time the glue remains liquid and workable. Joining parts after the open time is expired results in a weak bond. Hide glue's open time is usually a minute or less. In practice, this often means having to heat the pieces to be glued, and gluing in a very warm room, though these steps can be dispensed with if the glue and clamp operation can be carried out quickly. Where hide glue is in occasional use, excess glue may be held in a freezer, to prevent spoilage from the growth of microorganisms. Hide glue has some gap filling properties, although modern gap-filling adhesives, such as epoxy resin, are better in this regard. Hide glue that is liquid at room temperature is also possible through the addition of urea.
Cancer can arise in bone tissue, and bones are also a common site for other cancers to spread (metastasise) to. Cancers that arise in bone are called "primary" cancers, although such cancers are rare. Metastases within bone are "secondary" cancers, with the most common being breast cancer, lung cancer, prostate cancer, thyroid cancer, and kidney cancer. Secondary cancers that affect bone can either destroy bone (called a "lytic" cancer) or create bone (a "sclerotic" cancer). Cancers of the bone marrow inside the bone can also affect bone tissue, examples including leukemia and multiple myeloma. Bone may also be affected by cancers in other parts of the body. Cancers in other parts of the body may release parathyroid hormone or parathyroid hormone-related peptide. This increases bone reabsorption, and can lead to bone fractures. Bone tissue that is destroyed or altered as a result of cancers is distorted, weakened, and more prone to fracture. This may lead to compression of the spinal cord, destruction of the marrow resulting in bruising, bleeding and immunosuppression, and is one cause of bone pain. If the cancer is metastatic, then there might be other symptoms depending on the site of the original cancer. Some bone cancers can also be felt. Cancers of the bone are managed according to their type, their stage, prognosis, and what symptoms they cause. Many primary cancers of bone are treated with radiotherapy. Cancers of bone marrow may be treated with chemotherapy, and other forms of targeted therapy such as immunotherapy may be used.
Sources: en.wikipedia.org
== General and cited references == Greenwood, N. N.; Earnshaw, A. (1997). Chemistry of the Elements (2nd ed.). Butterworth-Heinemann. ISBN 978-0-08-037941-8. Stoll, W. (2005). "Thorium and Thorium Compounds". Ullmann's Encyclopedia of Industrial Chemistry. Wiley-VCH. doi:10.1002/14356007.a27_001. ISBN 978-3-527-31097-5. Wickleder, Mathias S.; Fourest, Blandine; Dorhout, Peter K. (2006). "Thorium". The Chemistry of the Actinide and Transactinide Elements. pp. 52–160. doi:10.1007/1-4020-3598-5_3. ISBN 978-1-4020-3555-5.
Iran warned it would hit all economic hubs in the Middle East, and any defensive European military involvement would be considered an act of war. On 4 March, US secretary of state Marco Rubio announced that the US-Israeli attacks on Iran would increase in intensity. Israel attacks hit the Basij headquarters. The IDF announced that an F-35I "Adir" shot down a Russian-made Iranian Yak-130 fighter jet over Tehran, the first time that an F-35 shot down a crewed fighter jet in air-to-air combat, and the first time the IAF shot down an aircraft since 1985. Iran launched strikes against the Al Udeid Air Base, and Aramco's Ras Tanura oil refining facility. The US ordered the evacuation of non-essential workers in Cyprus in anticipation of Iranian strikes. A ballistic missile launched from Iran was intercepted by NATO air defense systems as it entered Turkish airspace, marking an escalation in the conflict. Turkey asserted its right to self-defense after the missile landed in Dörtyol, Hatay Province, and NATO secretary general Mark Rutte stated that the alliance was committed to defending Turkey.
==== Miscellaneous laurasiatherian research ==== A study on the preservation of different kinds of steroids in bones of Ashoroa laticosta, Behemotops katsuiei and an unidentified whale from the Oligocene Morawan Formation (Japan) is published by Umamaheswaran et al. (2026). Matsui, Mitoh & Tsubamoto (2026) identify a purported humerus of a member of the genus Behemotops from the Miocene Chikubetsu Formation (Japan) as actually belonging to a juvenile member of the genus Desmostylus, and interpret the specimen as indicating that members of the genus Desmostylus expanded their range across Hokkaido during the Middle Miocene Climatic Optimum. Kramarz & Bond (2026) revise the composition of astrapothere assemblages from the Las Flores Formation (Argentina). Evidence of gradual increase of body mass of macraucheniids throughout their evolutionary history, likely linked to climate changes, is presented by Lobo, Gelfo & de Azevedo (2026). Wilson et al. (2026) determine that early hypsodont notoungulates from the Oligocene Tinguiririca Fauna (Chile) lived in an open, woody habitat, interpret the tooth wear of the studied notoungulates as consistent with a browsing diet, and interpret the evolution of their hypsodonty as unrelated to the expansion of grasslands. Redescription of the anatomy of Puelia plicata is published by Vera, Folino & Scarano (2026). A study on the phylogenetic relationships of toxodontid notoungulates is published by Armella & Deforel (2026). Armella et al.
==== Activation ==== Macrophages can achieve different activation phenotypes through interactions with different subsets of T helper cells, such as TH1 and TH2. Although there is a broad spectrum of macrophage activation phenotypes, there are two major phenotypes that are commonly acknowledged. They are the classically activated macrophages, or M1 macrophages, and the alternatively activated macrophages, or M2 macrophages. M1 macrophages are proinflammatory, while M2 macrophages are mostly anti-inflammatory.
Sources: en.wikipedia.org
NMN stands for nicotinamide mononucleotide. It is a naturally occurring nucleotide and an intermediate in the cellular production of NAD+.
No. NMN is a smaller precursor molecule, while NAD+ is a dinucleotide cofactor used in many reactions. Enzymes called NMNAT convert NMN into NAD+ inside cells.
This question is not fully settled. Some evidence suggests NMN may be dephosphorylated to nicotinamide riboside before uptake, while other studies propose direct transport. Tissue-specific handling in humans remains an open research area.
NMN stands for nicotinamide mononucleotide. It is a nucleotide intermediate in the cellular pathway that produces NAD+, a coenzyme involved in energy metabolism and signaling. NMN is not the same compound as NAD+.